96 related articles for article (PubMed ID: 30777785)
1. Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients.
Dong J; Shi GH; Lu M; Huang S; Liu YH; Yao JC; Li WY; Li LX
Pharmacogenomics; 2019 Feb; 20(3):167-177. PubMed ID: 30777785
[TBL] [Abstract][Full Text] [Related]
2. Methods for Predicting Warfarin Dose Requirements.
Saffian SM; Wright DF; Roberts RL; Duffull SB
Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients.
Xie C; Xue L; Zhang Y; Zhu J; Zhou L; Hang Y; Ding X; Jiang B; Miao L
Pharmacogenomics; 2020 Jan; 21(1):23-32. PubMed ID: 31849278
[No Abstract] [Full Text] [Related]
4. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
Cho SM; Lee KY; Choi JR; Lee KA
Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
[TBL] [Abstract][Full Text] [Related]
5. Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacement.
Zhao L; Chen C; Li B; Dong L; Guo Y; Xiao X; Zhang E; Qin L
PLoS One; 2014; 9(4):e94573. PubMed ID: 24728385
[TBL] [Abstract][Full Text] [Related]
6. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
[TBL] [Abstract][Full Text] [Related]
7. Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting.
Sasaki T; Tabuchi H; Higuchi S; Ieiri I
Pharmacogenomics; 2009 Aug; 10(8):1257-66. PubMed ID: 19663670
[TBL] [Abstract][Full Text] [Related]
8. Performance Evaluation of Warfarin Dose Prediction Algorithms and Effects of Clinical Factors on Warfarin Dose in Chinese Patients.
Gao W; Li Z; Chen W; Zhang S
Ther Drug Monit; 2021 Aug; 43(4):527-535. PubMed ID: 34250965
[TBL] [Abstract][Full Text] [Related]
9. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
[TBL] [Abstract][Full Text] [Related]
10. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
[TBL] [Abstract][Full Text] [Related]
11. Developing Chinese race-specific warfarin dose prediction algorithms.
Gao W; Zhang Z; Guan Z; Chen W; Li Z
Int J Clin Pharm; 2023 Jun; 45(3):731-738. PubMed ID: 36991222
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients.
Deng J; Wang Y; An X
J Clin Pharmacol; 2023 May; 63(5):569-582. PubMed ID: 36546564
[TBL] [Abstract][Full Text] [Related]
13. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
[TBL] [Abstract][Full Text] [Related]
14. Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.
Guo C; Kuang Y; Zhou H; Yuan H; Pei Q; Li J; Jiang W; Ng CM; Chen X; Huo Y; Cui Y; Wang X; Yu J; Sun X; Yu W; Chen P; Miao D; Liu W; Yu Z; Ouyang Z; Shi X; Lv C; Peng Z; Xiong G; Zeng G; Zeng J; Dai H; Peng J; Zhang Y; Xu F; Wu J; Chen X; Gong H; Yang Z; Wu X; Fang Q; Yang L; Li H; Tan H; Huang Z; Tang X; Yang Q; Tu S; Wang X; Xiang Y; Huang J; Wang X; Cai J; Jiang S; Huang L; Peng J; Gong L; Zou C; Yang G
Circ Genom Precis Med; 2020 Aug; 13(4):e002602. PubMed ID: 32510984
[TBL] [Abstract][Full Text] [Related]
15. Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M; Perreault S; Bahroun I; Lapointe M; Mongrain I; Provost S; Turgeon J; Talajic M; Brugada R; Phillips M; Tardif JC; Dubé MP
Pharmacogenomics; 2012 Jan; 13(1):21-9. PubMed ID: 22176621
[TBL] [Abstract][Full Text] [Related]
16. Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.
Saffian SM; Duffull SB; Roberts RL; Tait RC; Black L; Lund KA; Thomson AH; Wright DF
Ther Drug Monit; 2016 Dec; 38(6):677-683. PubMed ID: 27855133
[TBL] [Abstract][Full Text] [Related]
17. Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
Chen W; Wu L; Liu X; Shen Y; Liang Y; Zhu J; Tan H; Yang Y; Liu Q; Wang M; Liu L; Wang X
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):126-132. PubMed ID: 27117036
[TBL] [Abstract][Full Text] [Related]
18. Prediction of sensitivity to warfarin based on VKORC1 and CYP2C9 polymorphisms in patients from different places in Colombia.
Cifuentes RA; Murillo-Rojas J; Avella-Vargas E
Biomedica; 2016 Mar; 36(1):91-100. PubMed ID: 27622442
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic Warfarin Dosing Algorithms: Validity in Egyptian Patients.
Selim TE; Azzam HA; Ghoneim HR; Mohamed AA; El Wakeel H; Abu Bakr HM
Acta Haematol; 2018; 139(4):255-262. PubMed ID: 29996126
[TBL] [Abstract][Full Text] [Related]
20. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.
Miao L; Yang J; Huang C; Shen Z
Eur J Clin Pharmacol; 2007 Dec; 63(12):1135-41. PubMed ID: 17899045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
